Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             36 results found
no title author magazine year volume issue page(s) type
1 Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation Qayed, Muna

6 3 p. 746-749
article
2 ABCB6 polymorphisms are not overly represented in patients with porphyria Farrell, Colin P.

6 3 p. 760-766
article
3 A clinical laboratory–developed LSC17 stemness score assay for rapid risk assessment of patients with acute myeloid leukemia Ng, Stanley W.K.

6 3 p. 1064-1073
article
4 Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19 Wygrecka, Malgorzata

6 3 p. 1074-1087
article
5 An engineered activated factor V for the prevention and treatment of acute traumatic coagulopathy and bleeding in mice Joseph, Bilgimol Chumappumkal

6 3 p. 959-969
article
6 Antithrombin protects against Plasmodium falciparum histidine-rich protein II-mediated inflammation and coagulation Biswas, Indranil

6 3 p. 931-945
article
7 Antithymocyte globulin exposure in CD34+ T-cell–depleted allogeneic hematopoietic cell transplantation Lakkaraja, Madhavi

6 3 p. 1054-1063
article
8 ASXL1 and STAG2 are common mutations in GATA2 deficiency patients with bone marrow disease and myelodysplastic syndrome West, Robert R.

6 3 p. 793-807
article
9 Blinatumomab in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia: RIALTO expanded access study final analysis Locatelli, Franco

6 3 p. 1004-1014
article
10 Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19 Piñana, José Luis

6 3 p. 848-853
article
11 C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19 Aiello, Sistiana

6 3 p. 866-881
article
12 Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies Jiménez, Moraima

6 3 p. 774-784
article
13 Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myeloma Mohan, Meera

6 3 p. 808-817
article
14 Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia Kaur, Manraj N.

6 3 p. 785-792
article
15 Cumulative incidence of subsequent malignancy after allo-HCT conditioned with or without low-dose total body irradiation Nunez, Lina

6 3 p. 767-773
article
16 Daratumumab for immune thrombotic thrombocytopenic purpura van den Berg, Jana

6 3 p. 993-997
article
17 Decreased IL-10 accelerates B-cell leukemia/lymphoma in a mouse model of pediatric lymphoid leukemia Fitch, Briana A.

6 3 p. 854-865
article
18 Editorial Board
6 3 p. i
article
19 Epstein Barr virus–positive B-cell lymphoma is highly vulnerable to MDM2 inhibitors in vivo Zhang, Xiaoshan

6 3 p. 891-901
article
20 Expert-independent classification of mature B-cell neoplasms using standardized flow cytometry: a multicentric study Böttcher, Sebastian

6 3 p. 976-992
article
21 GRNDaD: big data and sickle cell disease Lanzkron, Sophie

6 3 p. 1088
article
22 Informing radiotherapy decisions in stage I/IIa Hodgkin lymphoma: modeling life expectancy using radiation dosimetry Jones, David A.

6 3 p. 909-919
article
23 LNK (SH2B3) inhibition expands healthy and Fanconi anemia human hematopoietic stem and progenitor cells Holdreith, Nicholas

6 3 p. 731-745
article
24 Morbidities and mortality in patients with hereditary thrombotic thrombocytopenic purpura Borogovac, Azra

6 3 p. 750-759
article
25 Multifaceted pathomolecular mechanism of a VWF large deletion involved in the pathogenesis of severe VWD Yadegari, Hamideh

6 3 p. 1038-1053
article
26 Nonneutralizing FVIII-specific antibody signatures in patients with hemophilia A and in healthy donors Schweiger, Helmut

6 3 p. 946-958
article
27 Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristics Hamadani, Mehdi

6 3 p. 920-930
article
28 Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphoma Bröske, Ann-Marie E.

6 3 p. 1025-1037
article
29 Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1 Oñate, Guadalupe

6 3 p. 882-890
article
30 Reduced cardiovascular morbidity in patients with hemophilia: results of a 5-year multinational prospective study Van Der Valk, Paul

6 3 p. 902-908
article
31 Response and survival predictors in a cohort of 319 patients with Waldenström macroglobulinemia treated with ibrutinib monotherapy Castillo, Jorge J.

6 3 p. 1015-1024
article
32 Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML Menghrajani, Kamal

6 3 p. 828-847
article
33 Sequential different B-cell antigen–targeted CAR T-cell therapy for pediatric refractory/relapsed Burkitt lymphoma Liu, Ying

6 3 p. 717-730
article
34 Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience Diarra, Ava

6 3 p. 998-1003
article
35 t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity Mueller, Sarah B.

6 3 p. 818-827
article
36 Vemurafenib acts as a molecular on-off switch governing systemic inflammation in Langerhans cell histiocytosis Eder, Sebastian K.

6 3 p. 970-975
article
                             36 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands